The other thing known is Ivermectin does real well in the lungs making it great for treating things that attack the lungs. I truly believe it helped my Covid bout...I had hardly any breathing issues even though I had 102 fever...I’ve seen far more that say it does, including numerous original FDA/NIH data…. Google it
As I understand it, The thing with Ivermectin, or any protease inhibitor (including Pfizermectin/Paxlovidis that they help block the virus from entering cells. Which means they have to be taken early in the first couple of days to show benefit. After that, the bug has invaded so many cells already that it’s too late to block them.
( it’s a far more complex affair than what I just described but that’s the layman’s version as I understand it)
The FLCCC protocol I follow includes preventative dosage and also includes other drugs and supplements. So while Ivermevtin is key, it’s not the only treatment.
I’ve seen a lot about vitamin D3/zinc and more recently melatonin as being big parts to prevention/early treatment as well.
Pandemic threat? Anyone else concerned?
- Thread starter erkme73
- Start date
Dad Burns $3,500 Worth Of Olivia Rodrigo Tickets Because Venue Demands Attendees Be Vaccinated For Covid-19
The anti-vaxxer posted the video in an attempt to take a stand against Olivia Rodrigo's 'Sour' tour, despite already paying the money.
bigredfish
Known around here
No idea who she is but good on him!
Damn, I remember concert tickets to the big names being $25-30 bucks
Damn, I remember concert tickets to the big names being $25-30 bucks
Oceanslider
Known around here
Exactly. This is the biggest human scam tragedy in my lifetime. And I will bet you it's in the 100's of Thousands. How many autopsy's were preformed after death?
Oceanslider
Known around here
Oceanslider
Known around here
I'd laugh at this one but this guy is such a joke to humanity, he just pisses me off anytime he comes on the radar.
Fauci Recommends Stopping Spread Of Monkeypox By Covering Eyes, Ears, Mouth
WASHINGTON, D.C.—The Monkeypox pandemic has finally breached the shores of the United States, with the CDC confirming a staggering 1 infections so far. In response, America's favorite, most trusted doctor, Dr. Anthony Fauci, issued a statement recommending people stop the spread of Monkeypox by...babylonbee.com
More than were performed before death.
Ssayer
BIT Beta Team
Ssayer
BIT Beta Team
Ssayer
BIT Beta Team
Ssayer
BIT Beta Team
Ssayer
BIT Beta Team
Oceanslider
Known around here
Ssayer
BIT Beta Team
Ssayer
BIT Beta Team
Ssayer
BIT Beta Team
Plastic surgeons created this study. Nothing wrong with that but what is their background in infectious disease lolOne of many early studies
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 - PMC
After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic ...www.ncbi.nlm.nih.gov
Here’s a recent one
Conclusion
Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir. To our knowledge, this is the largest association study of patients with COVID-19, mortality and ivermectin.
mat200
IPCT Contributor
- Jan 17, 2017
- 15,139
- 25,599
bigredfish
Known around here
ummm not what I’m reading…
Study conception and design: P. Kory and G. U. Meduri.
Pierre Kory MD, MPA
Pulmonary and Critical Care Specialist President and Chief Medical Officer Front Line COVID-19 Critical Care Alliance (FLCCC)
covid19criticalcare.com
Acquisition of data: Paul Marik and Jose Iglesias. Analysis and interpretation of data: Paul Marik, P. Kory, and Jose Iglesias. Drafting of manuscript: P. Kory. Critical revision: G. U. Meduri and Joseph Varon.
Paul E. Marik MD, FCCM, FCCP
Paul E. Marik MD, FCCM, FCCP, is a Pulmonary & Critical Care Specialist and founding member of FLCCC serving as Chairman & Chief Scientific Officer.
covid19criticalcare.com
And the data was largely gathered from over 80 papers and studies listed at the bottom of the article.
As stated this is simply one of many many early studies, over 60 peer reviewed.
Last edited:
bigredfish
Known around here
And if you’re referencing this study, they are researchers crunching numbers from publicly available data. They did no medical study themselves
Purpose
To evaluate the difference in mortality of patients treated with ivermectin vs patients treated with remdesivir with COVID-19 in United States using TriNetX Research network, a federated EMR network of over 44 healthcare organizations and 68 million patients from US, from 2009-2021.
Methods & Materials
We retrospectively identified adults (≥18 years) with a recorded COVID-19 infection between January 1, 2020 and July 11, 2021. We compared those with recorded use of ivermectin, but not remdesivir, against those with recorded use of remdesivir, but not ivermectin. We controlled for the following demographics, comorbidities, and treatments that may affect COVID-19 survival outcomes: age, gender, race, ethnicity, nicotine use diabetes mellitus, obesity, chronic lower respiratory disease, ischemic heart diseases, tocilizumab, glucocorticoids, or ventilator use. We measured association with mortality as the primary outcome, with significance assessed at p<0.05.
Results
There were a total of 1,761,060 possible COVID-19 patients based on ICD-10 diagnostic terms and confirmatory lab results. Prior to controlling, our analysis yielded 41,608 patients who had COVID-19 resulting in two unique cohorts that were treated with either ivermectin (1,072) or remdesivir (40,536). Within the ivermectin cohort, average age was 51.9 + 17.8 years, 43% were male, 60% had glucocorticoids and 1% required ventilator support. In the remdesivir cohort, average age was 62.0 + 16.0 years, 54% were male, 64% had glucocorticoids and 2% required ventilator support. After using propensity score matching and adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir (OR 0.308, 95% CI (0.198,0.479)),Risk Difference -5.224%, CI (-7.079%,-3.369%), p <0.0001.